Comparative Analysis of Incidence of Newly Developed Postoperative Low Back Pain with Field Block Versus Without Field-block Before Spinal Anaesthesia for Patients Undergoing Caesarean Sections
Launched by TATA MAIN HOSPITAL · Sep 15, 2024
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this study was to evaluate the effectiveness of field block with lidocaine 2% (5 ml) administered with a 24G hypodermic needle before spinal anesthesia for patients undergoing LSCS, in preventing the development of postoperative low back pain (PDPB). The study aimed to determine if using a field block would decrease the incidence of PDPB compared to patients who received only spinal anesthesia.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria: All patients undergoing LSCS under spinal anesthesia, ASA Grade 2 and Grade 2E and willing to participate in the trial
- • Exclusion Criteria: Spine pathology/instability and coagulopathy, ASA Grade 3 and above, Pre-exiting low back pain, Morbid Obesity (BMI \> 35), Patients needing more than 1 attempt for administration of spinal anaesthesia, Patients utilizing labour analgesia, Local infection or inflammation at the site of spinal anesthesia/field block, Unwilling to participate
- • -
About Tata Main Hospital
Tata Main Hospital (TMH) is a leading healthcare institution in India, renowned for its commitment to excellence in patient care, research, and education. As a prominent sponsor of clinical trials, TMH fosters innovative medical research aimed at advancing treatment options and improving health outcomes. With a multidisciplinary team of experienced healthcare professionals and state-of-the-art facilities, TMH is dedicated to conducting rigorous clinical studies that adhere to the highest ethical standards and regulatory requirements. The hospital's collaborative approach and focus on patient-centric research contribute to the development of safe and effective therapies, enhancing the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jamshedpur, Jharkhand, India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported